- Terapie časného HER2 pozitivního karcinomu prsu2022 | Publication without faculty affiliation
- Trastuzumab deruxtecan as standard of care for second-line treatment of metastatic HER2-positive breast cancer2023 | First Faculty of Medicine
- Is there a benefit of HER2-positive breast cancer subtype determination in clinical practice?2019 | First Faculty of Medicine, Third Faculty of Medicine
- Complete and long-term response of HER2 positive locally highly advanced metastatic breast cancer - case report2019 | Third Faculty of Medicine
- Experience in the treatment of advanced HER2 positive breast tumor in University Hospital in Motol2016 | Publication without faculty affiliation
- Trastuzumab deruxtecan: strong player in the field of metastatic HER2 positive breast cancer2022 | First Faculty of Medicine
- Targeted therapy in HER2-positive breast cancer2013 | Faculty of Medicine in Hradec Králové
- The current location of trastuzumab in the treatment of HER2 positive breast cancer2009 | First Faculty of Medicine
- Metastatic HER2-positive breast cancer - a new standard of treatment2015 | First Faculty of Medicine
- Adjuvantní a neoadjuvantní léčba časného HER pozitivního karcinomu prsu. Specifika léčby HER2 pozitivního / HR pozitivního karcinomu prsu2022 | Publication without faculty affiliation
- První a druhá linie léčby metastatického HER2 pozitivního karcinomu prsu2017 | First Faculty of Medicine
- Konjugáty protilátky a léčiva v léčbě HER2 pozitivního a HER2 low karcinomu prsu2023 | First Faculty of Medicine
- Neratinib in the context of an early breast cancer anti-HER2 therapy2020 | First Faculty of Medicine
- Adjuvantní léčba HER pozitivního karcinomu prsu2020 | First Faculty of Medicine
- What is new in histopathology of breast carcinoma2010 | Faculty of Medicine in Hradec Králové
- Neoadjuvant treatment of early breast cancer2019 | Publication without faculty affiliation
- Epidemiologie karcinomu prsu2017 | First Faculty of Medicine
- Trastuzumab-induced cardiotoxicity: a review2023 | Third Faculty of Medicine
- Review of tumor infiltrating lymphocytes assessment in breast cancer in routine diagnostic practice2021 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Third Faculty of Medicine
- Predictive diagnosis of breast cancer2011 | Faculty of Medicine in Hradec Králové
- Management of HER2-positive breast cancer, escalation and de-escalation of the therapy2017 | First Faculty of Medicine
- Hopes and pitfalls of the molecular classification of breast cancer2015 | Faculty of Medicine in Hradec Králové